Rockwell Automation (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced a strategic collaboration with ZETA, a global end-to-end solution provider for the pharma and biotech industry. Recognised as an expert in customer-specific project delivery, the ZETA Group excels in developing comprehensive automation concepts, ranging from engineering and design to full implementation and execution of independent stand-alone units with standard software to complete process control and Manufacturing Execution Systems (MES).
The Engineering, Procurement, and Construction (EPC) Partner Program is designed to bring together Rockwell Automation’s extensive industrial expertise and a select group of EPC companies to deliver cutting-edge automation and digital solutions to customers worldwide. By combining forces, the program aims to accelerate project delivery, improve efficiency, and drive greater value for customers in a rapidly evolving industrial landscape.
“We are proud to welcome ZETA into this designation,” said Polo Paredes, Regional Sales Director EPC Program Rockwell Automation. “Our EPC Partner Program reflects our commitment to driving innovation and collaboration in the industrial automation space. By working closely with a select group of EPC partners, we aim to deliver transformative solutions that help our customers achieve their operational goals more efficiently and effectively.”
Rockwell Automation partners with leading companies that have expertise in providing products and services designed to complement Rockwell Automation solutions. Becoming part of the Rockwell Automation PartnerNetwork signifies that these partners possess the expertise and track record necessary to offer our customers an unparalleled experience and gain a distinctive competitive edge. This prestigious designation is widely recognised as a compelling strategic opportunity, fostering growth, innovation, and untapped market potential for all involved.
“At ZETA, we understand the complexities of biopharmaceutical manufacturing. As an end-to-end solution provider, we manage major, highly complex biopharma projects to reduce project interfaces and risk ‒ from process engineering and construction to automation, digitalisation, and qualification. Our unique approach ensures the highest quality while significantly reducing delivery times of customer’s CAPEX projects by up to 50%, resulting in earlier creation of value,” says Lindsay Smart, CEO of ZETA USA.
“Our expertise in customised automation solutions, combined with our reputation for delivering high performance, reliability, and GMP-compliant quality, along with Rockwell Automation’s global capabilities and experience, provides our clients with exceptional results from the early design phases to the final project delivery. We are thrilled to continue our strategic partnership and offer unparalleled automation solutions to the pharmaceutical and biotech industries.”
For more information on the EPC Partner Program, please click here.